July 2022 "Orion Biotechnology and Peptilogics are pursuing AI-driven drug discovery to explore new functional

Coordinated transcriptomics and peptidomics of central nervous system identify neuropeptides and their Using peptidomic analysis of CNS of G. molesta, we identified total of 28 mature peptides and precursor-related

Orion has entered a strategic research collaboration with Peptilogics, a US-based AI drug discovery company

mouse models of chronic migraine, cortical spreading depression, and opioid-induced hyperalgesia with peptidomic